$5-Million Donation to Dana-Farber Cancer Institute Funds New Lung Cancer Study Center
Council member Dana-Farber Cancer Institute announced a new center for mutant lung cancer research after a $5 million gift to foster research for the mutations that affect 15% of Americans with lung cancer.
The gift, from California couple Phyllis Huang and Dr. Winston Chen, will be used to establish The Chen-Huang Center for Epidermal Growth Factor Receptor [EGFR] Mutant Lung Cancers. Dana-Farber became the first center in the United States to routinely test for EGFR mutations in lung cancer patients, which is now a standard practice around the world. The center will develop new clinical trials, studies, and therapeutic treatments, as well as educational opportunities for patients with mutant lung cancers and doctors and researchers who treat them.
Dr. Laurie Glimcher, president and CEO of Dana-Farber Cancer Institute said, “While we have made important progress in treating lung cancer, much more needs to be done. This generous gift will allow us to further push the boundaries of knowledge in this area to eventually develop new and better therapies. We are very grateful to Winston Chen and Phyllis Huang for their support to create this new center.”
The Council applauds Dana-Farber on its receiving of this generous gift to advance its research into lung cancer, and its commitment to developing new methods to improve patient care. Read more in the Boston Herald.